Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
- 23 February 2004
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (4), 941-945
- https://doi.org/10.1016/j.bmcl.2003.12.005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitorsBioorganic & Medicinal Chemistry, 2003
- 1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsBioorganic & Medicinal Chemistry Letters, 2002
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chainsBioorganic & Medicinal Chemistry Letters, 2002
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVBioorganic & Medicinal Chemistry Letters, 2002
- Combinatorial synthesis of CCR5 antagonistsBioorganic & Medicinal Chemistry Letters, 2001
- Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 AntagonistJournal of Medicinal Chemistry, 2001
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activityBioorganic & Medicinal Chemistry Letters, 2001
- Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanesBioorganic & Medicinal Chemistry Letters, 2001
- 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirementsBioorganic & Medicinal Chemistry Letters, 2001
- A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityProceedings of the National Academy of Sciences of the United States of America, 1999